Gennao Bio is a startup based in the United States, 1 tracked investor.
Based in the United States, Gennao Bio is a startup. Brouky records 1 investor associated with the company.
Gennao Bio is a genetic medicines company developing targeted nucleic acid therapeutics using a proprietary Gene Monoclonal Antibody (GMAB) platform that employs cell-penetrating antibodies to deliver nucleic acid payloads to selected cells. The company focuses its programs on oncology and rare skeletal muscle diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.